Global incidence and prevalence of nonalcoholic fatty liver disease
Margaret LP Teng, Cheng Han Ng, Daniel Q. Huang, Kai En Chan, Darren JH Tan, Wen Hui Lim, Ju Dong Yang, Eunice Tan, Mark D. Muthiah
Clin Mol Hepatol. 2023;29(Suppl):S32-S42.   Published online 2022 Dec 14     DOI: https://doi.org/10.3350/cmh.2022.0365
Citations to this article as recorded by Crossref logo
LDL-C and TC Mediate the Risk of PNPLA3 Inhibition in Cardiovascular Diseases
Genshan Zhang, Wei Jiang, Fangxun He, Jie Fu, Xiangshang Xu, Xuelai Luo, Zhixin Cao
The Journal of Clinical Endocrinology & Metabolism.2025; 110(2): e231.     CrossRef
Evolving Global Etiology of Hepatocellular Carcinoma (HCC): Insights and Trends for 2024
Abraham Koshy
Journal of Clinical and Experimental Hepatology.2025; 15(1): 102406.     CrossRef
Multicenter, multivendor validation of liver quantitative susceptibility mapping in patients with iron overload at 1.5 T and 3 T
Collin J. Buelo, Julia Velikina, Lu Mao, Ruiyang Zhao, Qing Yuan, Mounes Aliyari Ghasabeh, Stefan Ruschke, Dimitrios C. Karampinos, David T. Harris, Ryan J. Mattison, Michael R. Jeng, Ivan Pedrosa, Ihab R. Kamel, Shreyas Vasanawala, Takeshi Yokoo, Scott B
Magnetic Resonance in Medicine.2025; 93(1): 330.     CrossRef
A bio-guided search of anti-steatotic compounds in Opuntia stricta var. dillenii by fast centrifugal partition chromatography
Sayra N. Serrano-Sandoval, Sara Parralejo-Sanz, M. Gloria Lobo, M. Pilar Cano, Marilena Antunes-Ricardo
Food Chemistry.2025; 464: 141682.     CrossRef
Delphinidin or α‐amyrin attenuated liver steatosis and metabolic disarrangement in rats fed a high‐fat diet
Bassam Mohamed Ali, Eman M. Elbaz, Asmaa K. Al‐Mokaddem, Soad Z. El‐Emam, Magdy M. Awny
BioFactors.2025;[Epub]     CrossRef
Female C57BL/6 mice exhibit protection against nonalcoholic fatty liver disease and diabesity accompanied by differential regulation of hepatic lipocalin prostaglandin D2 synthase
Md Asrarul Islam, Rhema Khairnar, Joshua Fleishman, Sandra E. Reznik, Louis Ragolia, Shruthi Gobbooru, Sunil Kumar
Molecular and Cellular Endocrinology.2025; 595: 112404.     CrossRef
Sex Hormone: A Potential Target at Treating Female Metabolic Dysfunction-Associated Steatotic Liver Disease?
Huiyan Duan, Minmin Gong, Gang Yuan, Zhi Wang
Journal of Clinical and Experimental Hepatology.2025; 15(2): 102459.     CrossRef
Characteristics and survival of patients with viral versus nonviral associated hepatocellular carcinoma: a multicenter cohort study
Mohamed El-Kassas, Eman M.F. Barakat, Hend Ibrahim Shousha, Mohamed Kohla, Mohamed Said, Ehab Fawzy Moustafa, Ahmed Tawheed, Mostafa Abd Alfattah Shamkh, Mohamed Mahmoud Nabeel, Eman Elkhateeb, Hossam Dabees, Mohamed Omar Abdelmalek, Hamdy Sayed, Nourhan
European Journal of Gastroenterology & Hepatology.2025; 37(1): 83.     CrossRef
FrozONE: quick cell nucleus enrichment for comprehensive proteomics analysis of frozen tissues
Lukas A Huschet, Fabian P Kliem, Peter Wienand, Claudia M Wunderlich, Andrea Ribeiro, Isabel Bustos-Martínez, Ángel Barco, F Thomas Wunderlich, Maciej Lech, Maria S Robles
Life Science Alliance.2025; 8(3): e202403130.     CrossRef
Quantitative Liver Fat Assessment by Handheld Point-of-Care Ultrasound: A Technical Implementation and Pilot Study in Adults
Dorathy Tamayo-Murillo, Jake T. Weeks, Cody A. Keller, Michael Andre, Celene Gonzalez, Andrew Li, Eduardo Grunvald, Joy Liau, Sedighe Hosseini Shabanan, Tanya Wolfson, Jingyi Zuo, Adam Robinson, Carolina Amador Carrascal, Nevada Sanchez, Scott B. Reeder,
Ultrasound in Medicine & Biology.2025; 51(3): 475.     CrossRef
Human umbilical cord derived-mesenchymal stem cells alleviate lipid metabolism disturbances of hepatocytes via mitochondrial transport
Jing Xue, Xiangnan Hu, Suying Xia, Pengfei Ren, Aihong Wang
Gastroenterology & Endoscopy.2025; 3(1): 47.     CrossRef
Insights of direct and indirect regulation of PXR through phosphorylation in fatty liver disease
Veronia Basaly, Anisha Bhattacharya, Grace L. Guo
Molecular Pharmacology.2025; 107(2): 100014.     CrossRef
The impact of diet-induced obesity on 5 fluorouracil-induced tumor and liver immune cell cytotoxicity
Brandon N. VanderVeen, Thomas D. Cardaci, Brooke M. Bullard, Christian A. Unger, Jeffrey C. Freeman, Reilly T. Enos, Michael Shtutman, Michael D. Wyatt, Daping Fan, E. Angela Murphy
American Journal of Physiology-Cell Physiology.2025; 328(1): C56.     CrossRef
Fermented rhubarb alleviates metabolic dysfunction-associated steatotic liver disease symptoms by modulating gut microbiota and activating the hepatic insulin signaling pathway
Heng Yuan, Junyu Zhou, Ting Zhang, Xuangao Wu, Chen Li, Hee-Jong Yang, Do Yeon Jeong, Sunmin Park
Food Bioscience.2025; 63: 105720.     CrossRef
Exploring the hepatic benefits of skipjack tuna (Katsuwonus pelamis) dark muscle hydrolysate in high-fat diet-induced non-alcoholic fatty liver disease
Fangfang Huang, Qingfei Dai, Kewei Zheng, Qingbao Ma, Yu Liu, Wei Jiang, Xiaojun Yan
Food Bioscience.2025; 63: 105786.     CrossRef
Ginsenoside Rg1: A bioactive therapeutic agent for diverse liver diseases
Mingyu Wu, Ke Li, Jiabin Wu, Xianyi Ding, Xiaotong Ma, Wenhong Wang, Weihua Xiao
Pharmacological Research.2025; 212: 107571.     CrossRef
The relationship between anthropometric indices and non-alcoholic fatty liver disease in adults: a cross-sectional study
Mina Radmehr, Reza Homayounfar, Abolghasem Djazayery
Frontiers in Nutrition.2025;[Epub]     CrossRef
Monascus pilosus SWM-008 red mold rice and its components, monascinol and monascin, reduce obesity in a high-fat diet-induced rat model through synergistic modulation of gut microbiota and anti-lipogenesis
Chin-Feng Liu, Hui-Tzu Chuang, Chia-Shu Wang, Ya-Wen Hsu, Tzu-Ming Pan, Chun-Lin Lee
Food & Function.2025;[Epub]     CrossRef
Association between triglyceride-glucose (TyG) related indices and cardiovascular diseases and mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study of UK Biobank
Yanan Qiao, Yue Wang, Cheng Chen, Yueqing Huang, Chunhua Zhao
Cardiovascular Diabetology.2025;[Epub]     CrossRef
A Novel Point-of-Care Prediction Model for Steatotic Liver Disease: Expected Role of Mass Screening in the Global Obesity Crisis
Jeayeon Park, Goh Eun Chung, Yoosoo Chang, So Eun Kim, Won Sohn, Seungho Ryu, Yunmi Ko, Youngsu Park, Moon Haeng Hur, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
Gut and Liver.2025; 19(1): 126.     CrossRef
Bioinformatic Analysis for Exploring Target Genes and Molecular Mechanisms of Cadmium‐Induced Nonalcoholic Fatty Liver Disease and Targeted Drug Prediction
Le Zhang, Rui Wang, Qian Xue, Yongjie Wang, Jiayunzhu Xu, Chaofan Wang, Xin Fang, Shidi Gao, Haiying Zhang, Li Guo
Journal of Applied Toxicology.2025;[Epub]     CrossRef
Association between non-alcoholic fatty liver disease and progression of abdominal aortic aneurysm: a multicenter study
Ximing Wang, Jingxiang Sun, Na Chang, Menghan Liu, Shuai Zhang
BMC Medical Imaging.2025;[Epub]     CrossRef
Cell–cell communications in the brain of hepatic encephalopathy: The neurovascular unit
Kyuwan Choi, Yena Cho, Yerin Chae, So Yeong Cheon
Life Sciences.2025; 363: 123413.     CrossRef
Associations between systemic inflammatory biomarkers and metabolic dysfunction associated steatotic liver disease: a cross-sectional study of NHANES 2017–2020
Xin Qiu, Shuang Shen, Nizhen Jiang, Yifei Feng, Guodong Yang, Donghong Lu
BMC Gastroenterology.2025;[Epub]     CrossRef
The cross–sectional association between ultra-processed food intake and metabolic dysfunction-associated steatotic liver disease
Natalie Sun, Brenton Prescott, Jiantao Ma, Vanessa Xanthakis, Paula A. Quatromoni, Michelle T. Long, Maura E. Walker
Clinical Nutrition ESPEN.2025; 66: 215.     CrossRef
Risk factor assessment of prediabetes and diabetes based on epidemic characteristics in new urban areas: a retrospective and a machine learning study
Li Xu, Xiangcheng Sun, Ning Wang, Yiyi Wang, Yan Li, Chuan Zhang
Scientific Reports.2025;[Epub]     CrossRef
Development of non-alcoholic steatohepatitis is associated with gut microbiota but not with oxysterol enzymes CH25H, EBI2, or CYP7B1 in mice
Jacqueline Wyss, Tina Raselli, Annika Wyss, Anja Telzerow, Gerhard Rogler, Niklas Krupka, Bahtiyar Yilmaz, Thomas S. B. Schmidt, Benjamin Misselwitz
BMC Microbiology.2024;[Epub]     CrossRef
Dose finding for ZSP1601 in patients with nonalcoholic steatohepatitis using population pharmacokinetics and exposure–response approach
Haijun Li, Yue Hu, Yuting Yang, Fengyan Xu, Zhongyi Sun, Jufang Huang, Kun Wang, Xiaoxin Chen
European Journal of Pharmaceutical Sciences.2024; 199: 106808.     CrossRef
Dietary Pattern’s Role in Hepatic Epigenetic and Dietary Recommendations for the Prevention of NAFLD
Josefina I. Martín Barraza, David Bars-Cortina
Nutrients.2024; 16(17): 2956.     CrossRef
Assessment of melatonin’s therapeutic effectiveness against hepatic steatosis induced by a high-carbohydrate high-fat diet in rats
Davood Dorranipour, Fahimeh Pourjafari, Reza Malekpour-Afshar, Mohsen Basiri, Mehran Hosseini
Naunyn-Schmiedeberg's Archives of Pharmacology.2024; 397(5): 2971.     CrossRef
Association of five diet scores with severe NAFLD incidence: A prospective study from UK Biobank
Fanny Petermann‐Rocha, Fernanda Carrasco‐Marin, Jirapitcha Boonpor, Solange Parra‐Soto, Oliver Shannon, Fiona Malcomson, Nathan Phillips, Mahek Jain, Salil Deo, Katherine M. Livingstone, Sara E. Dingle, John C. Mathers, Ewan Forrest, Frederick K. Ho, Jill
Diabetes, Obesity and Metabolism.2024; 26(3): 860.     CrossRef
The effects of pomegranate consumption on liver function enzymes in adults: A systematic review and meta-analysis
Hossein Bahari, Hossein Rafiei, Kian Goudarzi, Kosar Omidian, Omid Asbaghi, Kosar Sadat Hosseini Kolbadi, Moslem Naderian, Ali Hosseini
Complementary Therapies in Medicine.2024; 80: 103008.     CrossRef
BDE-47 induces metabolic dysfunction-associated steatotic liver disease (MASLD) through CD36-mediated increased fatty acid uptake and PPARα-induced abnormal fatty acid oxidation in BALB/c mice
Beibei Xia, Rongfei Yu, Junxiong Liu, Dongmeng Liu, Shasha Li, Liu Yang, Nan Liu, Bosen Liang, Jiajing Zeng, Jinhua Wei, Guimiao Lin
Toxicology Letters.2024; 391: 100.     CrossRef
Ameliorative role of bioactive phytoconstituents targeting obesity associated NAFLD by modulation of inflammation and lipogenesis pathways: a comprehensive review
Pervej Alom Barbhuiya, Saikat Sen, Manash Pratim Pathak
Phytochemistry Reviews.2024; 23(4): 969.     CrossRef
Multifocal fatty liver nodules mimicking a metastatic disease: A case report
Huy Quang Duong, Shinya Kajiura, Tien Dinh Truong, Minh Tuan Ngo, Khai Xuan Nguyen, Hung Khanh Pham, Thang Ba Ta, Dung Tien Nguyen, Ryuji Hayashi
Radiology Case Reports.2024; 19(3): 850.     CrossRef
Role of Perturbated Hemostasis in MASLD and Its Correlation with Adipokines
Salvatore Pezzino, Tonia Luca, Mariacarla Castorina, Stefano Puleo, Saverio Latteri, Sergio Castorina
Life.2024; 14(1): 93.     CrossRef
The Intersection of Genetic Factors, Aberrant Nutrient Metabolism and Oxidative Stress in the Progression of Cardiometabolic Disease
Andrew J. Butcko, Ashley K. Putman, Emilio P. Mottillo
Antioxidants.2024; 13(1): 87.     CrossRef
Bacillus coagulans TCI711 Supplementation Improved Nonalcoholic Fatty Liver by Modulating Gut Microbiota: A Randomized, Placebo-Controlled, Clinical Trial
Rong-Hong Hsieh, Yu-Ju Chien, Wen-Yi Lan, Yung-Kai Lin, Yung-Hsiang Lin, Chi-Fu Chiang, Ming-Ta Yang
Current Developments in Nutrition.2024; 8(3): 102083.     CrossRef
Altered lipid metabolism as a predisposing factor for liver metastasis in MASLD
So Jung Kim, Jeongeun Hyun
Molecules and Cells.2024; 47(2): 100010.     CrossRef
Steatotic liver disease predicts cardiovascular disease and advanced liver fibrosis: A community-dwelling cohort study with 20-year follow-up
Hun Jee Choe, Joon Ho Moon, Won Kim, Bo Kyung Koo, Nam H. Cho
Metabolism.2024; 153: 155800.     CrossRef
Association between dairy-rich dietary pattern and metabolic dysfunction-associated steatotic liver disease: Findings from the Korean Genome and Epidemiology Study
Jong Hee Lee, Hye Sun Lee, Soyoung Jeon, Jun-Hyuk Lee, Yu-Jin Kwon
Digestive and Liver Disease.2024; 56(9): 1529.     CrossRef
Beneficial Effects of Dietary Flaxseed on Non-Alcoholic Fatty Liver Disease
Mihir Parikh, Broderick C. Hirst, Kimberley A. O’Hara, Thane G. Maddaford, J. Alejandro Austria, Aleksandra Stamenkovic, Liping Yu, Branislav Kura, Bhavana Garg, Thomas Netticadan, Spencer D. Proctor, Grant N. Pierce
Nutrients.2024; 16(4): 466.     CrossRef
The Portal Venous Pulsatility Index and Main Portal Vein Diameter as Surrogate Markers for Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Metabolic-Dysfunction-Associated Steatotic Liver Disease
Jaejun Lee, Seungmyeon Choi, Seong-Hyun Cho, Hyun Yang, Pil-Soo Sung, Si-Hyun Bae
Diagnostics.2024; 14(4): 393.     CrossRef
Association between healthy beverage index and nonalcoholic fatty liver disease in the Ravansar noncommunicable disease cohort study
Sepehr Sadafi, Ali Azizi, Shahab Rezaeian, Yahya Pasdar
Scientific Reports.2024;[Epub]     CrossRef
Upper limit of normal ALT levels in health and metabolic diseases: Pooled analysis of 423,355 individuals with bootstrap modelling
Eunice X. Tan, Daniel Q. Huang, Natasha Tang Sook Yee, Zi Hui Wan, Sanjna N. Nerurkar, Justin Chua Ying Kai, Kang Shiong Goh, Cheng Han Ng, Mark Muthiah, Yu Zhou, Amanda Woodward, Michael H. Le, Yee Hui Yeo, Scott Barnett, Ramsey Cheung, Mindie H. Nguyen
Alimentary Pharmacology & Therapeutics.2024; 59(8): 984.     CrossRef
Assessing the clinical and biochemical efficacy of alpha-lipoic acid in patients with non-alcoholic fatty liver disease: A randomized placebo-controlled clinical trial
Mehrangiz Ebrahimi-Mameghani, Somayyeh Asghari, Fatemeh Naeini, Mahdiyeh Taghizadeh, Soudabeh Hamedi-Shahraki, Farshad Amirkhizi
Journal of Functional Foods.2024; 114: 106050.     CrossRef
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
Mohamed El-Kassas, Abeer Awad, Mohamed Elbadry, Juan Pablo Arab
Seminars in Liver Disease.2024; 44(01): 054.     CrossRef
Perilipin 5 deletion protects against nonalcoholic fatty liver disease and hepatocellular carcinoma by modulating lipid metabolism and inflammatory responses
Paola Berenice Mass-Sanchez, Marinela Krizanac, Paula Štancl, Marvin Leopold, Kathrin M. Engel, Eva Miriam Buhl, Josef van Helden, Nikolaus Gassler, Jürgen Schiller, Rosa Karlić, Diana Möckel, Twan Lammers, Steffen K. Meurer, Ralf Weiskirchen, Anastasia A
Cell Death Discovery.2024;[Epub]     CrossRef
The Interplay Between Dietary Choline and Cardiometabolic Disorders: A Review of Current Evidence
Natalia G. Vallianou, Dimitris Kounatidis, Sotiria Psallida, Fotis Panagopoulos, Theodora Stratigou, Eleni Geladari, Irene Karampela, Dimitrios Tsilingiris, Maria Dalamaga
Current Nutrition Reports.2024; 13(2): 152.     CrossRef
Metabolic Dysfunction-Associated Steatotic Liver Disease in a Dish: Human Precision-Cut Liver Slices as a Platform for Drug Screening and Interventions
Mei Li, Frederik T. Larsen, Marius C. van den Heuvel, Konstanze Gier, Alan R. Gorter, Dorenda Oosterhuis, Johan Bijzet, Vincent E. de Meijer, Kim Ravnskjaer, Anika Nagelkerke, Peter Olinga
Nutrients.2024; 16(5): 626.     CrossRef
Advancing Endocrine Disruptors via In Vitro Evaluation: Recognizing the Significance of the Organization for Economic Co-Operation and Development and United States Environmental Protection Agency Guidelines, Embracing New Assessment Methods, and the Urge
Sophie Fouyet, Marie-Caroline Ferger, Pascale Leproux, Patrice Rat, Mélody Dutot
Toxics.2024; 12(3): 183.     CrossRef
Therapeutic potential of Triphala and Gomutra in the management of non-alcoholic fatty liver disease: A review
M S Deepa, V C Indulekha, Indu M Menon
Journal of Drug Research in Ayurvedic Sciences.2024; 9(1): 8.     CrossRef
Role of Vibration-Controlled Transient Elastography in the Evaluation and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease
Elizabeth E. Williams, Raj Vuppalanchi
Current Hepatology Reports.2024; 23(3): 355.     CrossRef
4,4‐Diallyl curcumin bis(2,2‐hydroxymethyl)propanoate ameliorates nonalcoholic steatohepatitis in methionine‐choline‐deficient diet and Western diet mouse models
Li‐Chan Yang, Chih‐Chiang Wang, Der‐Yen Lee, Wen‐Chuan Lin, Sheng‐Chu Kuo, Shin‐Hun Juang, Min‐Tsang Hsieh
Chemical Biology & Drug Design.2024;[Epub]     CrossRef
A Cloud-Based System for Automated AI Image Analysis and Reporting
Neil Chatterjee, Jeffrey Duda, James Gee, Ameena Elahi, Kristen Martin, Van Doan, Hannah Liu, Matthew Maclean, Daniel Rader, Arijitt Borthakur, Charles Kahn, Hersh Sagreiya, Walter Witschey
Journal of Imaging Informatics in Medicine.2024;[Epub]     CrossRef
Adipocytokines as Predictors of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Development in Type 2 Diabetes Mellitus Patients
Almir Fajkić, Rijad Jahić, Almira Hadžović-Džuvo, Orhan Lepara
Cureus.2024;[Epub]     CrossRef
Beyond the hype and toward application: liver complex in vitro models in preclinical drug safety
Sushma Jadalannagari, Lorna Ewart
Expert Opinion on Drug Metabolism & Toxicology.2024; 20(7): 607.     CrossRef
Anti-osteoporotic treatments in the era of non-alcoholic fatty liver disease: friend or foe
Maria Eleni Chondrogianni, Ioannis Kyrou, Theodoros Androutsakos, Christina-Maria Flessa, Evangelos Menenakos, Kamaljit Kaur Chatha, Yekaterina Aranan, Athanasios G. Papavassiliou, Eva Kassi, Harpal S. Randeva
Frontiers in Endocrinology.2024;[Epub]     CrossRef
Interleukins: Pathogenesis in Non-Alcoholic Fatty Liver Disease
Saira Rafaqat, Sanja Gluscevic, Filiz Mercantepe, Sana Rafaqat, Aleksandra Klisic
Metabolites.2024; 14(3): 153.     CrossRef
Glucocorticoid resistance remodels liver lipids and prompts lipogenesis, eicosanoid, and inflammatory pathways
Genesee J. Martinez, Zachary A. Kipp, Wang-Hsin Lee, Evelyn A. Bates, Andrew J. Morris, Joseph S. Marino, Terry D. Hinds
Prostaglandins & Other Lipid Mediators.2024; 173: 106840.     CrossRef
Depalmitoylation and cell physiology: APT1 as a mediator of metabolic signals
Sarah L. Speck, Xiaochao Wei, Clay F. Semenkovich
American Journal of Physiology-Cell Physiology.2024; 326(4): C1034.     CrossRef
Metabolic Dysfunction-Associated Steatohepatitis and Progression to Hepatocellular Carcinoma: A Literature Review
Haider Ghazanfar, Nismat Javed, Abeer Qasim, George Sarin Zacharia, Ali Ghazanfar, Abhilasha Jyala, Elona Shehi, Harish Patel
Cancers.2024; 16(6): 1214.     CrossRef
Effects of Resveratrol on Liver Function Tests in Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis of Randomized Controlled Trials
P. Ebrahimpour, M. Karamian, A. Sharifi
Russian Journal of Gastroenterology, Hepatology, Coloproctology.2024; 34(1): 37.     CrossRef
Effect of Gracilaria vermiculophylla Macroalga on Non-Alcoholic Fatty Liver Disease in Obese Rats
Maitane González-Arceo, Leixuri Aguirre, María Teresa Macarulla, Clàudia Gil-Pitarch, María Luz Martínez-Chantar, María P. Portillo, Saioa Gómez-Zorita
Antioxidants.2024; 13(3): 369.     CrossRef
Response to Article “Effect of Helicobacter Pylori Infection on Glucose Metabolism, Lipid Metabolism and Inflammatory Cytokines in Nonalcoholic Fatty Liver Disease Patients” [Letter]
Putu Yuliandari, I Putu Bayu Mayura
Journal of Multidisciplinary Healthcare.2024; Volume 17: 1413.     CrossRef
Possibilities of a new assessment scale for prediction of chronic liver disease “CLivD”
L. B. Lazebnik, S. V. Turkina
Experimental and Clinical Gastroenterology.2024; (11): 62.     CrossRef
Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)?
Kamila Kasprzak-Drozd, Przemysław Niziński, Paulina Kasprzak, Adrianna Kondracka, Tomasz Oniszczuk, Agata Rusinek, Anna Oniszczuk
International Journal of Molecular Sciences.2024; 25(7): 3746.     CrossRef
Bariatrics and endoscopic therapies for the treatment of metabolic disease: Past, present, and future
Geltrude Mingrone, Harith Rajagopalan
Diabetes Research and Clinical Practice.2024; 211: 111651.     CrossRef
NAFLD in the 21st Century: Current Knowledge Regarding Its Pathogenesis, Diagnosis and Therapeutics
Dimitris Kounatidis, Natalia G. Vallianou, Eleni Geladari, Maria Paraskevi Panoilia, Anna Daskou, Theodora Stratigou, Irene Karampela, Dimitrios Tsilingiris, Maria Dalamaga
Biomedicines.2024; 12(4): 826.     CrossRef
Namodenoson at the Crossroad of Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular Carcinoma
Ohad Etzion, Avital Bareket-Samish, David Yardeni, Pnina Fishman
Biomedicines.2024; 12(4): 848.     CrossRef
Association between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction: A 7-year retrospective cohort study of 3,380 adults using serial echocardiography
Gyuri Kim, Tae Yang Yu, Jae Hwan Jee, Ji Cheol Bae, Mira Kang, Jae Hyeon Kim
Diabetes & Metabolism.2024; 50(3): 101534.     CrossRef
The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation
Ludovico Abenavoli, Maria Luisa Gambardella, Giuseppe Guido Maria Scarlata, Ilaria Lenci, Leonardo Baiocchi, Francesco Luzza
Medicina.2024; 60(4): 563.     CrossRef
Gestational supplementation of Bifidobacterium, Lactobacillus, and Streptococcus thermophilus attenuates hepatic steatosis in offspring mice through promoting fatty acid β‐oxidation
Hangjun Chen, Qiongmei Wu, Xingyi Chen, Xinxue Yu, Hanqing Zhao, Qiaoli Huang, Yurong Huang, Jinting Wang, Xueyi Huang, Jun Wei, Feng Wu, Xiaomin Xiao, Lijun Wang
Journal of Food Science.2024; 89(5): 3064.     CrossRef
Changes in the terminology and diagnostic criteria of non-alcoholic fatty liver disease: Implications and opportunities
Muhammed Mubarak
World Journal of Gastrointestinal Pathophysiology.2024;[Epub]     CrossRef
Non-alcoholic fatty liver disease: a current challenge of interdisciplinary research
E. V. Biryukova
Meditsinskiy sovet = Medical Council.2024; (6): 72.     CrossRef
Can Plasma Volume Determination in Cirrhosis Be Replaced by an Algorithm Using Body Weight and Hematocrit?
Martine Prütz Nørskov, Thormod Mønsted, Nina Kimer, Morten Damgaard, Søren Møller
Diagnostics.2024; 14(8): 835.     CrossRef
From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences
Ahmed M. Samy, Mohamed A. Kandeil, Dina Sabry, A.A. Abdel-Ghany, Mohamed O. Mahmoud
Heliyon.2024; 10(9): e30387.     CrossRef
Efficacy and safety of aldafermin in non-alcoholic steatohepatitis: A systematic review and meta-analysis of randomized controlled trials
Mohamed Mahmoud Marey, Mohamed Belal, Abdelaziz A. Awad, Eslam Mohammed Rabea, Malak A. Hassan, Ahmed W. Abbas, Abdulqadir J. Nashwan
Clinics and Research in Hepatology and Gastroenterology.2024; 48(6): 102357.     CrossRef
A prospective observational cross-sectional study on the association of non-alcoholic fatty liver disease and insulin resistance in acute ischemic stroke in tertiary care hospital in Central India
Dr. Jayanth Kumar, Dr Anuj Varma, Dr Sourya Acharya, Dr Sunil Kumar
F1000Research.2024; 13: 434.     CrossRef
Liver steatosis in patients with transfusion‐dependent thalassaemia
Paolo Ricchi, Laura Pistoia, Vincenzo Positano, Anna Spasiano, Tommaso Casini, Maria Caterina Putti, Zelia Borsellino, Antonella Cossu, Giuseppe Messina, Petra Keilberg, Carmina Fatigati, Silvia Costantini, Stefania Renne, Giuseppe Peritore, Filippo Cadem
British Journal of Haematology.2024; 204(6): 2458.     CrossRef
Diagnostic performances of Fibrosis‐4 index and nonalcoholic fatty liver disease fibrosis score in metabolic dysfunction‐associated steatotic liver disease in Asian primary care clinics
Huiyul Park, Mimi Kim, Hye‐Lin Kim, Seon Cho, Eileen L. Yoon, Dae Won Jun
Hepatology Research.2024; 54(11): 1027.     CrossRef
Obesity, liver steatosis and metabolic syndrome: The hidden enemies in transfusion‐dependent thalassaemia
Padmapani Padeniya, Anuja Premawardhena
British Journal of Haematology.2024; 205(1): 28.     CrossRef
Personalized medicine and nutrition in hepatology for preventing chronic liver disease in Mexico
Arturo Panduro, Sonia Roman, Irene M. Mariscal-Martinez, Alexis Jose-Abrego, Karina Gonzalez-Aldaco, Claudia Ojeda-Granados, Omar Ramos-Lopez, Luis A. Torres-Reyes
Frontiers in Nutrition.2024;[Epub]     CrossRef
Management of Cardiovascular Risk in the Non‑alcoholic Fatty Liver Disease Setting
Paula Luque-Linero, Luis Castilla-Guerra
European Cardiology Review.2024;[Epub]     CrossRef
WFUMB Guideline/Guidance on Liver Multiparametric Ultrasound: Part 1. Update to 2018 Guidelines on Liver Ultrasound Elastography
Giovanna Ferraioli, Richard Gary Barr, Annalisa Berzigotti, Ioan Sporea, Vincent Wai‐Sun Wong, Thomas Reiberger, Thomas Karlas, Maja Thiele, Ana Carolina Cardoso, Oyekoya Taiwo Ayonrinde, Laurent Castera, Christoph Frank Dietrich, Hiroko Iijima, Dong Ho L
Ultrasound in Medicine & Biology.2024; 50(8): 1071.     CrossRef
Metabolic dysfunction associated steatotic liver disease in patients with plaque psoriasis: a case–control study and serological comparison
Zheng Lin, Yue-yi Shi, Lu-yan Yu, Chen-xi Ma, Si-yi Pan, Yuan Dou, Qiu-jun Zhou, Yi Cao
Frontiers in Medicine.2024;[Epub]     CrossRef
MASLD-mimicking microenvironment drives an aggressive phenotype and represses IDH2 expression in hepatocellular carcinoma
Peyda Korhan, Ezgi Bağırsakçı, Yasemin Öztemur Islakoğlu, Gülhas Solmaz, Burcu Sarıkaya, Deniz Nart, Funda Yılmaz, Neşe Atabey
Hepatoma Research.2024;[Epub]     CrossRef
Combined Insults of a MASH Diet and Alcohol Binges Activate Intercellular Communication and Neutrophil Recruitment via the NLRP3-IL-1β Axis in the Liver
Mrigya Babuta, Prashanth Thevkar Nagesh, Aditi Ashish Datta, Victoria Remotti, Yuan Zhuang, Jeeval Mehta, Francesca Lami, Yanbo Wang, Gyongyi Szabo
Cells.2024; 13(11): 960.     CrossRef
Prebiotic Treatment in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)—A Randomized Pilot Trial
Naama Reshef, Uri Gophna, Leah Reshef, Fred Konikoff, Gila Gabay, Taiba Zornitzki, Hilla Knobler, Yaakov Maor
Nutrients.2024; 16(11): 1571.     CrossRef
Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD
Farah Abdelhameed, Chris Kite, Lukasz Lagojda, Alexander Dallaway, Kamaljit Kaur Chatha, Surinderjeet S. Chaggar, Maria Dalamaga, Eva Kassi, Ioannis Kyrou, Harpal S. Randeva
Current Obesity Reports.2024; 13(3): 510.     CrossRef
Mast cells and the gut-liver Axis: Implications for liver disease progression and therapy
Bhagyalakshmi Nair, Adithya Jayaprakash Kamath, Vinay Tergaonkar, Gautam Sethi, Lekshmi R. Nath
Life Sciences.2024; 351: 122818.     CrossRef
Emerging role of natural lipophagy modulators in metabolic dysfunction–associated steatotic liver disease
Nahla E. El-Ashmawy, Eman G. Khedr, Ghada M. Al-Ashmawy, Asmaa A. Kamel
Nutrition.2024; 126: 112517.     CrossRef
Unravelling the complexities of non-alcoholic steatohepatitis: The role of metabolism, transporters, and herb-drug interactions
Ravi Adinarayan Somabattini, Sahla Sherin, Bhukya Siva, Neelanjan Chowdhury, Satheesh Kumar Nanjappan
Life Sciences.2024; 351: 122806.     CrossRef
Clinical improvement effect of regulating gut microbiota on metabolic dysfunction-associated steatotic liver disease: Systematic review and meta-analysis of randomized controlled trials
Juan Wu, Xiaoyang Chen, Jun Qian, Guochun Li
Clinics and Research in Hepatology and Gastroenterology.2024; 48(7): 102397.     CrossRef
Interplay of Mediterranean-diet adherence, genetic factors, and metabolic dysfunction-associated steatotic liver disease risk in Korea
Yu-Jin Kwon, Ja-Eun Choi, Kyung-Won Hong, Ji-Won Lee
Journal of Translational Medicine.2024;[Epub]     CrossRef
Diagnostic performance of sixteen biomarkers for MASLD: A study in a Mexican cohort
Bryan Adrian Priego-Parra, Sara Alejandra Reyes-Diaz, Héctor Ricardo Ordaz-Alvarez, Raúl Bernal-Reyes, Maria Eugenia Icaza-Chávez, Sophia Eugenia Martínez-Vázquez, Mercedes Amieva-Balmori, Héctor Vivanco-Cid, José Antonio Velarde-Ruiz Velasco, Jordi Graci
Clinics and Research in Hepatology and Gastroenterology.2024; 48(7): 102400.     CrossRef
Evaluation of the diagnostic role of circulating miR-16, miR-10b, and miR-21 expression in patients with nonalcoholic fatty liver disease
Fatemeh Amani, Amirhossein Sahebkar, Seyed Hamid Aghaee-Bakhtiari, Mohammadreza Farzanehfar, Saeedeh Askarian, Reza Kazemi Oskuee
Gene Reports.2024; 36: 101964.     CrossRef
Bifidobacterium longumBL‐19 inhibits oxidative stress and inflammatory damage in the liver of mice with NAFLD by regulating the production of butyrate in the intestine
Xiajun Zhang, Jingwen Xu, Xueyun Dong, Jiajun Tang, Yan Xie, Jie Yang, Limin Zou, Liang Wu, Jilong Fan
Food Science & Nutrition.2024; 12(9): 6442.     CrossRef
Targeting cAMP signaling and phosphodiesterase 4 for liver disease treatment
Jingyi Ma, Dalton W. Staler, Ram I. Mahato
Medicinal Chemistry Research.2024; 33(8): 1339.     CrossRef
Mapping global research trends: Nutrition associations with nonalcoholic fatty liver disease - a Scopus bibliometric analysis
Muna Shakhshir, Sa'ed H Zyoud
World Journal of Gastroenterology.2024; 30(24): 3106.     CrossRef
The systemic inflammation response index as a risk factor for hepatic fibrosis and long-term mortality among individuals with metabolic dysfunction-associated steatotic liver disease
Yufeng Yin, Weijia Zhu, Qingling Xu
Nutrition, Metabolism and Cardiovascular Diseases.2024; 34(8): 1922.     CrossRef
Mapping the global research landscape on nonalcoholic fatty liver disease and insulin resistance: A visualization and bibliometric study
Sa'ed H Zyoud, Omar E Hegazi, Samer O Alalalmeh, Muna Shakhshir, Faris Abushamma, Shadi Khilfeh, Samah W Al-Jabi
World Journal of Hepatology.2024; 16(6): 951.     CrossRef
Evaluation of the role of some non-enzymatic antioxidants among Iraqi patients with non-alcoholic fatty liver disease
Ammar L. Hussein, Dunia T. Nema, Gulboy A. Nasir
Open Life Sciences.2024;[Epub]     CrossRef
Effect of synbiotic supplementation on liver function, metabolic profile and gut microbiota in non-alcoholic fatty liver disease (NAFLD): A meta-analysis of randomized controlled trials
Jihan Fadhilah, Hainun Zariyah, Adriyan Pramono, Hery Djagat Purnomo, Ahmad Syauqy, Diana Nur Afifah, Farhan Syafiq Fadhillah, Rachmania Anggita Purwanti
Clinical Nutrition Open Science.2024; 56: 128.     CrossRef
Experimental investigation for nonalcoholic fatty pancreas management using probiotics
Marwa Matboli, Hiba S. Al-Amodi, Shaimaa Hamady, Marwa Ali, Marian MS Roushdy, Amany Helmy Hasanin, Yasmin M. Aboul-Ela, Reda Albadawy, Eman Gomaa, Hala F. M. Kamel, Hind A ELsawi, Laila M. Farid, Mariam B. Abouelkhair, Gena M Elmakromy, Nesma Mohamed Faw
Diabetology & Metabolic Syndrome.2024;[Epub]     CrossRef
An examination of global research trends for exploring the associations between the gut microbiota and nonalcoholic fatty liver disease through bibliometric and visualization analysis
Sa’ed H. Zyoud, Samer O. Alalalmeh, Omar E. Hegazi, Muna Shakhshir, Faris Abushamma, Samah W. Al-Jabi
Gut Pathogens.2024;[Epub]     CrossRef
Role of Nonalcoholic Fatty Liver Disease in Periodontitis: A Bidirectional Relationship
Hardika S Vegda, Bhavin Patel, Gaurav A Girdhar, Mohd. Shabankhan H Pathan, Rahnuma Ahmad, Mainul Haque, Susmita Sinha, Santosh Kumar
Cureus.2024;[Epub]     CrossRef
Diagnostic performance of CT/MRI LI-RADS v2018 in non-cirrhotic steatotic liver disease
Jennie Cao, Andy Shon, Luke Yoon, Aya Kamaya, Justin R. Tse
European Radiology.2024; 34(12): 7622.     CrossRef
NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment Options
Natalia G. Vallianou, Dimitris Kounatidis, Sotiria Psallida, Nikolaos Vythoulkas-Biotis, Andreas Adamou, Tatiana Zachariadou, Sofia Kargioti, Irene Karampela, Maria Dalamaga
Metabolites.2024; 14(7): 366.     CrossRef
Association between different obesity patterns and the risk of NAFLD detected by transient elastography: a cross-sectional study
Jingjing Sun, Chun Yan, Jing Wen, Fang Wang, Han Wu, Fang Xu
BMC Gastroenterology.2024;[Epub]     CrossRef
Linking physiology and demographics, non‐ocular pathology and pharmaceutical drug use to standard OCT measures of the inner retina: The PPP project
Matt Trinh, Kelly O., Melanie La, Angelica Ly
Ophthalmic and Physiological Optics.2024; 44(6): 1128.     CrossRef
A review on cell-free RNA profiling: Insights into metabolic diseases and predictive value for bariatric surgery outcomes
Manvita Mareboina, Elen Deng, Ioannis Mouratidis, Nelson S. Yee, Nelly Pitteloud, Ilias Georgakopoulos-Soares, Dionysios V. Chartoumpekis
Molecular Metabolism.2024; 87: 101987.     CrossRef
Management of Metabolic-Associated Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease: From Medication Therapy to Nutritional Interventions
Mohammad Beygi, Salma Ahi, Samaneh Zolghadri, Agata Stanek
Nutrients.2024; 16(14): 2220.     CrossRef
“Winning the peace” against obesity in recipients of liver transplant
Kevin Pak, Sammy Saab
Liver Transplantation.2024; 30(10): 979.     CrossRef
Molybdenum’s Role as an Essential Element in Enzymes Catabolizing Redox Reactions: A Review
Jakub Piotr Adamus, Anna Ruszczyńska, Aleksandra Wyczałkowska-Tomasik
Biomolecules.2024; 14(7): 869.     CrossRef
Barriers to care linkage and educational impact on unnecessary MASLD referrals
Jun-Hyuk Lee, Eileen Laurel Yoon, Ju Hyun Oh, Kyunam Kim, Sang Bong Ahn, Dae Won Jun
Frontiers in Medicine.2024;[Epub]     CrossRef
Effectiveness of mobile health intervention for non alcoholic fatty liver disease- A meta analysis of randomized controlled trials
Rohit Kumar, Monika Rani, Ramsha, Vanesh Kumar, Sahil Kumar, Johar Abbas, Savanti, Monika Kumari, Aakash Kumar, Santosh, Muhammad Sohaib Asghar
Clinics and Research in Hepatology and Gastroenterology.2024; 48(8): 102433.     CrossRef
Effects of Propolis Consumption on Glycemic Indices and Liver Enzymes in Adults: A Grading of Recommendations Assessment, Development, and Valuation-assessed Systematic Review and Dose-Response Meta-analysis
Shaghayegh Adeli, Mahsa Maroofi, Fatemeh Pourteymour Fard Tabrizi, Beitullah Alipour, Marzieh Heidari, Mahdi Vajdi, Mahdieh Abbasalizad-Farhangi
Clinical Therapeutics.2024; 46(9): e6.     CrossRef
Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes
Merve Cebi, Yusuf Yilmaz
Frontiers in Immunology.2024;[Epub]     CrossRef
A male mouse model for metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma
Byung-Kwan Jeong, Won-Il Choi, Wonsuk Choi, Jieun Moon, Won Hee Lee, Chan Choi, In Young Choi, Sang-Hyun Lee, Jung Kuk Kim, Young Seok Ju, Pilhan Kim, Young-Ah Moon, Jun Yong Park, Hail Kim
Nature Communications.2024;[Epub]     CrossRef
Mechanistic Insights into the Biological Effects and Antioxidant Activity of Walnut (Juglans regia L.) Ellagitannins: A Systematic Review
Letiția Mateș, Roxana Banc, Flaviu Andrei Zaharie, Marius Emil Rusu, Daniela-Saveta Popa
Antioxidants.2024; 13(8): 974.     CrossRef
The Predictive Value of Time‐Varying Noninvasive Scores on Long‐Term Prognosis of NAFLD in South Korea
Sung Won Chung, Min Kyung Park, Xiao Zhang, Tongtong Wang, Thomas Jemielita, Gail Fernandes, Samuel S. Engel, Heejoon Jang, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim, Xingshun Qi
Canadian Journal of Gastroenterology and Hepatology.2024;[Epub]     CrossRef
Agile 3+ and Agile 4 scores predict chronic kidney disease development in metabolic dysfunction‐associated steatotic liver disease
Chan‐Young Jung, Jung Il Lee, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
Alimentary Pharmacology & Therapeutics.2024; 60(8): 1051.     CrossRef
Therapeutic Effects of Semaglutide on Nonalcoholic Fatty Liver Disease with Type 2 Diabetes Mellitus and Obesity: An Open-Label Controlled Trial
Ahmed I. Gad, Nevin F. Ibrahim, Noura Almadani, Rasha Mahfouz, Hanaa A. Nofal, Dina S. El-Rafey, Hossam Tharwat Ali, Amr T. EL-Hawary, Ayman M. E. M. Sadek
Diseases.2024; 12(8): 186.     CrossRef
Effect of metabolic dysfunction‐associated steatotic liver disease on BNT162b2 immunogenicity against the severe acute respiratory syndrome coronavirus 2 omicron variant
Lok Ka Lam, Jing Tong Tan, Poh Hwa Ooi, Ruiqi Zhang, Kwok Hung Chan, Xianhua Mao, Ivan F N Hung, Wai Kay Seto, Man Fung Yuen, Ka Shing Cheung
Journal of Gastroenterology and Hepatology.2024; 39(11): 2386.     CrossRef
Protective effects of syringic acid in nonalcoholic fatty liver in rats through regulation of Nrf2/HO‐1 signaling pathway
Simiao Zhang, Sheng Zheng, Ya Li, Juan Yang, Xiaozhou Mao, Tao Liu, Qiuxin Zhang, ZhiPeng Fu, Xing Zhu, Long Xu
Journal of Biochemical and Molecular Toxicology.2024;[Epub]     CrossRef
Intermittent fasting and the liver: Focus on the Ramadan model
Mohamed H Emara, Hanan Soliman, Ebada M Said, Hassan Elbatae, Mostafa Elazab, Shady Elhefnawy, Tarik I Zaher, Ahmed Abdel-Razik, Mohamed Elnadry
World Journal of Hepatology.2024; 16(8): 1070.     CrossRef
Trimethylamine N-oxide: a meta-organismal axis linking the gut and fibrosis
Jae Woong Jang, Emma Capaldi, Tracy Smith, Priyanka Verma, John Varga, Karen J. Ho
Molecular Medicine.2024;[Epub]     CrossRef
Shift work and non-alcoholic fatty liver disease in young, healthy workers
Yesung Lee, Woncheol Lee
Scientific Reports.2024;[Epub]     CrossRef
Prevalence of nonalcoholic fatty liver disease in Pakistan: a systematic review and meta-analysis
Fazal Hassan, Maria Farman, Kauser Aftab Khan, Muhammad Awais, Sohail Akhtar
Scientific Reports.2024;[Epub]     CrossRef
Analyzing and evaluating the prevalence and metabolic profile of lean NAFLD compared to obese NAFLD: a systemic review and meta-analysis
Hareer Fatima, Hussain Sohail Rangwala, Muhammad Saqlain Mustafa, Muhammad Ashir Shafique, Syed Raza Abbas, Burhanuddin Sohail Rangwala
Therapeutic Advances in Endocrinology and Metabolism.2024;[Epub]     CrossRef
Protective effect of β-sitosterol against high-fructose diet-induced oxidative stress, and hepatorenal derangements in growing female sprague-dawley rats
Nontobeko M. Gumede, Busisani W. Lembede, Pilani Nkomozepi, Richard L. Brooksbank, Kennedy H. Erlwanger, Eliton Chivandi
Laboratory Animal Research.2024;[Epub]     CrossRef
Vaccinium spp. Berries in the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease: A Comprehensive Update of Preclinical and Clinical Research
Ewelina Książek, Zuzanna Goluch, Marta Bochniak
Nutrients.2024; 16(17): 2940.     CrossRef
Heavy metals are liver fibrosis risk factors in people without traditional liver disease etiologies
Ning Ma, Meena B. Bansal, Jaime Chu, Mark Woodward, Andrea D. Branch
Journal of Environmental Sciences.2024;[Epub]     CrossRef
Association between neutrophil-to-high-density lipoprotein cholesterol ratio and metabolic dysfunction-associated steatotic liver disease and liver fibrosis in the US population: a nationally representative cross-sectional study using NHANES data from 201
Yangni Lu, Xianli Xu, Jianlin Wu, Lei Ji, Huiya Huang, Maowei Chen
BMC Gastroenterology.2024;[Epub]     CrossRef
Metabolic risk factors of colorectal cancer: Umbrella review
Meseret Derbew Molla, Erin L. Symonds, Jean M. Winter, Ayal Debie, Molla M. Wassie
Critical Reviews in Oncology/Hematology.2024; 204: 104502.     CrossRef
Evaluation of MRI proton density fat fraction in hepatic steatosis: a systematic review and meta-analysis
Narges Azizi, Hamed Naghibi, Madjid Shakiba, Mina Morsali, Diana Zarei, Hedayat Abbastabar, Hossein Ghanaati
European Radiology.2024;[Epub]     CrossRef
Emerging Therapies for Non-Alcoholic Steatohepatitis (NASH): A Comprehensive Review of Pharmacological and Non-Pharmacological Approaches
Shradha P Kakde, Maham Mushtaq, Maryyam Liaqat, Husnain Ali, Muhammad Muaz Mushtaq, Muhammad Asad Sarwer, Sami Ullah, Muhammad Wali Hassan, Asma Khalid, Syed Faqeer Hussain Bokhari
Cureus.2024;[Epub]     CrossRef
Comparison of the Grades of Fatty Liver Disease With Perioperative Risk Factors in Patients With Laparoscopic Sleeve Gastrectomy
Yalçın Burak Kara, Yahya Ozel
Cureus.2024;[Epub]     CrossRef
Detección de enfermedad hepática avanzada incorporando el uso de la elastografía de transición en atención primaria
Mar Noguerol Álvarez, Ma Paz Valer López Fando, Carolina Torrijos Bravo, Ma Carmen Gómez Ortiz, Belén Piqueras Alcohol, Antonio Guardiola Arévalo, Gema De la Poza Gómez, Zahara Pascual García, Sandra Rey Rodríguez, Raquel Iglesias Sigüenza, Esther Ledesma
Gastroenterología y Hepatología.2024; : 502242.     CrossRef
Key challenges of post-liver transplant weight management
Maja Cigrovski Berkovic, Vibor Šeša, Ivan Balen, Quirino Lai, Hrvoje Silovski, Anna Mrzljak
World Journal of Transplantation.2024;[Epub]     CrossRef
Characterizing Unique Clinical and Virological Profiles in Concurrent Chronic Hepatitis B and Metabolic Dysfunction-Associated Liver Disease: Insights from a Population-Based Cohort Study
Fadi Abu Baker, Abdel-Rauf Zeina, Randa Taher, Saif Abu Mouch, Ariel Israel
Journal of Clinical Medicine.2024; 13(18): 5608.     CrossRef
Metabolic dysfunction‐associated steatotic liver disease and MetALD increases the risk of liver cancer and gastrointestinal cancer: A nationwide cohort study
Yewan Park, Jooyi Jung, Seungbong Han, Gi‐Ae Kim
Alimentary Pharmacology & Therapeutics.2024; 60(11-12): 1599.     CrossRef
The association between alcohol consumption and cardiometabolic factors and liver fibrosis in metabolic dysfunction‐associated steatotic liver disease and metabolic dysfunction and alcohol‐associated liver disease
Masahiro Sogabe, Toshiya Okahisa, Miwako Kagawa, Takanori Kashihara, Ryo Shinomiya, Takanori Miyake, Tomoyuki Kawaguchi, Reiko Yokoyama, Kaizo Kagemoto, Yoshifumi Kida, Yasuyuki Okada, Tetsu Tomonari, Yutaka Kawano, Yasushi Sato, Masahiko Nakasono, Tetsuj
Alimentary Pharmacology & Therapeutics.2024; 60(11-12): 1587.     CrossRef
Polymorphism of PNPLA3 and TM6SF2 genes in patients with nonalcoholic fatty liver disease resident at Gomel region
N. S. Branovitskaya
Health and Ecology Issues.2024; 21(3): 45.     CrossRef
Dietary D-lactate intake ameliorates metabolic syndrome via enhancing brown adipose tissue thermogenesis in diet-induced obese mice
Zhijie Yao, Jinxiang Chen, Xiaojing Li, Shuxiao Liang, Hao Zhang, Haitao Li, Wei Chen
Food Bioscience.2024; 62: 105284.     CrossRef
Impact of Non-Alcoholic Fatty Liver Disease on Sepsis Inpatient Outcomes: A Nationwide Sample Analysis (2000–2019)
Xiuhong Lyu, Bolun Liu, Yiting Li, Yichen Wang, John Miskovsky, Melissa Gaitanis, Kittichai Promrat, Wen-Chih Wu
Journal of Clinical Medicine.2024; 13(19): 5737.     CrossRef
The nonlinear connection between relative fat mass and non-alcoholic fatty liver disease in the Japanese population: an analysis based on data from a cross-sectional study
Changchun Cao, Meiling Huang, Yong Han, Xiaohua Zhang, Haofei Hu, Yulong Wang
Diabetology & Metabolic Syndrome.2024;[Epub]     CrossRef
Polycystic ovary syndrome: a multisystemic approach to metabolic dysfunctions – review
Elena Popa, Ana-Aurelia Chiş-Şerban, Mihaela Poroch, Andrei-Emilian Popa, Raluca-Ioana Avram, Adorata-Elena Coman
Medic.ro.2024; 4(160): 49.     CrossRef
Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis
Young Eun Chon, Young-Joo Jin, Jihyun An, Hee Yeon Kim, Miyoung Choi, Dae Won Jun, Mi Na Kim, Ji Won Han, Han Ah Lee, Jung Hwan Yu, Seung Up Kim
Clinical and Molecular Hepatology.2024; 30(Suppl): S117.     CrossRef
Long-term antibody response after the third dose of inactivated SARS-CoV-2 vaccine in MASLD patients
Jin Cui, Lianbang Wang, Armin Ghavamian, Xuemei Li, Gongzheng Wang, Tao Wang, Min Huang, Qi Ru, Xinya Zhao
BMC Gastroenterology.2024;[Epub]     CrossRef
Comparative associations of MASLD and MAFLD with the presence and severity of coronary artery calcification
Min Kyu Kang, Jeong Eun Song, Rohit Loomba, Soo Young Park, Won Young Tak, Young Oh Kweon, Yu Rim Lee, Jung Gil Park
Scientific Reports.2024;[Epub]     CrossRef
Construction and comparative analysis of an early screening prediction model for fatty liver in elderly patients based on machine learning
Xiaolei Cai, Qi Sun, Cen Qiu, Zhenyu Xie, Jiahao He, Mengting Tu, Xinran Zhang, Yang Liu, Zhaojun Tan, Yutong Xie, Xixuan He, Yujing Ren, Chunhong Xue, Siqi Wang, Linrong Yuan, Miao Yu, Xuelin Cheng, Xiaopan Li, Sunfang Jiang, Huirong Zhu
Progress in Medical Devices.2024;[Epub]     CrossRef
Understanding Insulin Resistance in NAFLD: A Systematic Review and Meta-Analysis Focused on HOMA-IR in South Asians
Margeyi Mehta, Jigish Shah, Urvish Joshi
Cureus.2024;[Epub]     CrossRef
Ubiquitin-specific peptidase 25 ameliorates hepatic steatosis by stabilizing peroxisome proliferator-activated receptor alpha
Peihao Liu, Xin Song, Qingxia Chen, Li Cen, Chenxi Tang, Chaohui Yu, Chengfu Xu
Journal of Biological Chemistry.2024; 300(11): 107876.     CrossRef
Targeting histamine in metabolic syndrome: Insights and therapeutic potential
Yiting Wang, Fude Fang, Xiaojun Liu
Life Sciences.2024; 358: 123172.     CrossRef
Metformin: Beyond Type 2 Diabetes Mellitus
Rahnuma Ahmad, Mainul Haque
Cureus.2024;[Epub]     CrossRef
A Scoping Review on Hepatoprotective Mechanism of Herbal Preparations through Gut Microbiota Modulation
Chin Long Poo, Mei Siu Lau, Nur Liana Md Nasir, Nik Aina Syazana Nik Zainuddin, Mohd Rahimi Ashraf Abd Rahman, Siti Khadijah Mustapha Kamal, Norizah Awang, Hussin Muhammad
Current Issues in Molecular Biology.2024; 46(10): 11460.     CrossRef
Beyond the Heart: The Predictive Role of Coronary Artery Calcium Scoring in Non-Cardiovascular Disease Risk Stratification
Viviana Cortiana, Hetvee Vaghela, Rahul Bakhle, Tony Santhosh, Oroshay Kaiwan, Aalia Tausif, Ashish Goel, Mohammed K. Suhail, Neil Patel, Omar Akram, Nirja Kaka, Yashendra Sethi, Arsalan Moinuddin
Diagnostics.2024; 14(21): 2349.     CrossRef
Gut Microbiota Dysbiosis in the Pathogenesis of Metabolic-dysfunction Associated Steatotic Liver Disease (MASLD)
Gh Jeelani Mir, Nissar Ul Ashraf
The International Journal of Gastroenterology and Hepatology Diseases.2024;[Epub]     CrossRef
Amino acid is a major carbon source for hepatic lipogenesis
Yilie Liao, Qishan Chen, Lei Liu, Haipeng Huang, Jingyun Sun, Xiaojie Bai, Chenchen Jin, Honghao Li, Fangfang Sun, Xia Xiao, Yahong Zhang, Jia Li, Weiping Han, Suneng Fu
Cell Metabolism.2024; 36(11): 2437.     CrossRef
Fibroblast growth factor 21: update on genetics and molecular biology
Daniel R. Barros, Robert A. Hegele
Current Opinion in Lipidology.2024;[Epub]     CrossRef
“Regulation of adipose-derived fatty acid flux to the liver”-Impact on metabolic dysfunction-associated steatotic liver disease
Erika Folestad, Annelie Falkevall
Current Opinion in Endocrine and Metabolic Research.2024; 37: 100559.     CrossRef
S-Adenosylmethionine (SAMe) for Liver Health: A Systematic Review
Kyrie Baden, Halley McClain, Eliya Craig, Nathan Gibson, Juanita Draime, Aleda Chen
Nutrients.2024; 16(21): 3668.     CrossRef
Vitamin E and Non-alcoholic Fatty Liver Disease: Investigating the Evidence Through a Systematic Review
Mahlet Abera, Suchith B Suresh, Aparna Malireddi, Sruthi Boddeti, Khutaija Noor, Mehwish Ansar, Iana Malasevskaia
Cureus.2024;[Epub]     CrossRef
Ursolic acid: A promising therapeutic agent for metabolic dysfunction-associated steatotic liver disease via inhibition of SPP1-induced Th17 cell differentiation: Editorial on “Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against
So Jung Kim, Jeongeun Hyun
Clinical and Molecular Hepatology.2024; 30(4): 709.     CrossRef
Machine-Learning Application for Predicting Metabolic Dysfunction-Associated Steatotic Liver Disease Using Laboratory and Body Composition Indicators
Fatemeh Masaebi, Mehdi Azizmohammad Looha, Morteza Mohammadzadeh, Vida Pahlevani, Mojtaba Farjam, Farid Zayeri, Reza Homayounfar
Archives of Iranian Medicine.2024; 27(10): 551.     CrossRef
Inhibiting Ferroptosis Prevents the Progression of Steatotic Liver Disease in Obese Mice
Gi Cheol Park, Soo-Young Bang, Ji Min Kim, Sung-Chan Shin, Yong-il Cheon, Kwang Min Kim, Hanaro Park, Eui-Suk Sung, Minhyung Lee, Jin-Choon Lee, Byung-Joo Lee
Antioxidants.2024; 13(11): 1336.     CrossRef
The NRF-2/HO-1 Signaling Pathway: A Promising Therapeutic Target for Metabolic Dysfunction-Associated Steatotic Liver Disease
Na Li, Liyuan Hao, Shenghao Li, Jiali Deng, Fei Yu, Junli Zhang, Aiyu Nie, Xiaoyu Hu
Journal of Inflammation Research.2024; Volume 17: 8061.     CrossRef
Longer sitting times and bulk amounts of rice intake are associated with the increased risks of metabolic dysfunction-associated fatty liver diseases (MAFLD): A case-control study
Shahinul Alam, Mahbuba Kawser, Saif Uddin Nisar Ahmed, Md Mahabubul Alam, Md Saiful Islam, Shayla Nasrin
Clinical Nutrition Open Science.2024; 58: 275.     CrossRef
Cardiovascular and nonalcoholic fatty liver disease: Sharing common ground through SIRT1 pathways
Kenneth Maiese
World Journal of Cardiology.2024; 16(11): 632.     CrossRef
The Interplay of Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: A Call for Integrated Management
Carmine Zoccali, Francesca Mallamaci
American Journal of Nephrology.2024; : 1.     CrossRef
Correlation of non-alcoholic fatty liver disease and neurodegenerative disorders
Pranali A. Jadhav, Asha B. Thomas, Vinay M. Chopada, Prajay V. Bokaria, Shivam B. Deokate, Pankaj S. Chougule, Pruthviraj N. Chavan, Sohan S. Chitlange
Egyptian Liver Journal.2024;[Epub]     CrossRef
Quercetin: A Promising Candidate for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Julia Markowska, Kamila Kasprzak-Drozd, Przemysław Niziński, Magdalena Dragan, Adrianna Kondracka, Ewa Gondek, Tomasz Oniszczuk, Anna Oniszczuk
Molecules.2024; 29(22): 5245.     CrossRef
Metabolic-associated steatotic liver disease and hepatocellular carcinoma
Giovanni Catalano, Odysseas P. Chatzipanagiotou, Jun Kawashima, Timothy M. Pawlik
Expert Opinion on Pharmacotherapy.2024; 25(17): 2283.     CrossRef
Association of dietary inflammatory index with sarcopenia in patients with Metabolic dysfunction-associated fatty liver disease: a cross-sectional study
Xianyao Wang, Rongjie Shi, Ying Zi, Jun Long
Frontiers in Nutrition.2024;[Epub]     CrossRef
Inhibition of the miR-1914-5p increases the oxidative metabolism in cellular model of steatosis by modulating the Sirt1-PGC-1α pathway and systemic cellular activity
Thais Porto-Barbosa, Letícia Ferreira Ramos, Camila Cristiane Pansa, Letícia Ramos Molica, Osmar Malaspina, Karen C. M. Moraes, Prasanth Puthanveetil
PLOS ONE.2024; 19(11): e0313185.     CrossRef
Advances in liver engineering with cell, scaffold, and vascularization
Chunyan Liu, Yulian Wang, Xuqian Zhou, Lei Dong
EngMedicine.2024; 1(3): 100041.     CrossRef
Establishment and characterization of mouse metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma organoids
Sumin Kim, Nahyun Jeong, Jeayeon Park, Hyojin Noh, Ja Oh Lee, Su Jong Yu, Ja-Lok Ku
Scientific Reports.2024;[Epub]     CrossRef
Application and mechanism of Chinese herb medicine in the treatment of non-alcoholic fatty liver disease
Yuqiao Liu, Yue Fan, Jibin Liu, Xiyang Liu, Xiuyan Li, Jingqing Hu
Frontiers in Pharmacology.2024;[Epub]     CrossRef
Liver-related aspects of valoctocogene roxaparvovec gene therapy for hemophilia A: expert guidance for clinical practice
Vincenzo La Mura, Vincenzo Cardinale, Raimondo De Cristofaro, Adriano De Santis, Giovanni Di Minno, Luca Fabris, Fabio Marra, Filomena Morisco, Flora Peyvandi, Maurizio Pompili, Cristina Santoro, Ezio Zanon, Giancarlo Castaman
Blood Advances.2024; 8(22): 5725.     CrossRef
Jolkinolide B Ameliorates Liver Inflammation and Lipogenesis by Regulating JAK/STAT3 Pathway
Hye-Rin Noh, Guoyan Sui, Jin Woo Lee, Feng Wang, Jeong-Su Park, Yuanqiang Ma, Hwan Ma, Ji-Won Jeong, Dong-Su Shin, Xuefeng Wu, Bang-Yeon Hwang, Yoon Seok Roh
Biomolecules & Therapeutics.2024; 32(6): 793.     CrossRef
The correlation between metabolic dysfunction-associated steatotic liver disease (MASLD) grades and hemodynamic alterations of the portal, hepatic, and splenic vein and spleen size
Soheila Borji, Hadi Sabat Sani, Saharnaz Ghorbani, Mohammad Soltani, Vahid Mohammadi, Reza Elahi
Journal of Ultrasound.2024;[Epub]     CrossRef
High-Sensitivity C-Reactive Protein Levels in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic Alcohol-Associated Liver Disease (MetALD), and Alcoholic Liver Disease (ALD) with Metabolic Dysfunction
Seong-Uk Baek, Jin-Ha Yoon
Biomolecules.2024; 14(11): 1468.     CrossRef
Spirulina platensis Peptide-Loaded Nanoliposomes Alleviate Hepatic Lipid Accumulation in Male Wistar Rats by Influencing Redox Homeostasis and Lipid Metabolism via the AMPK Signaling Pathway
Katayoon Karimzadeh, Suraj Unniappan, Asgar Zahmatkesh
Applied Biochemistry and Biotechnology.2024;[Epub]     CrossRef
Revolutionizing the understanding of liver disease: Metabolism, function and future
Arnulfo E Morales-Galicia, Mariana M Ramírez-Mejía, Guadalupe Ponciano-Rodriguez, Nahum Méndez-Sánchez
World Journal of Hepatology.2024; 16(12): 1365.     CrossRef
A Comprehensive Analysis of Liver Lipidomics Signature in Adults with Metabolic Dysfunction-Associated Steatohepatitis—A Pilot Study
Thomai Mouskeftara, Georgios Kalopitas, Theodoros Liapikos, Konstantinos Arvanitakis, Eleni Theocharidou, Georgios Germanidis, Helen Gika
International Journal of Molecular Sciences.2024; 25(23): 13067.     CrossRef
Implementation of Machine Learning Algorithms to Screen for Advanced Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: An In-Depth Explanatory Analysis
Shoham Dabbah, Itamar Mishani, Yana Davidov, Ziv Ben Ari
Digestion.2024; : 1.     CrossRef
MRI-PDFF Assessment of Intrahepatic Fat Changes Post-Bariatric Surgery: A Systematic Literature Review
Danut Dejeu, Paula Dejeu, Anita Muresan, Paula Bradea, Viorel Dejeu
Medicina.2024; 60(12): 2003.     CrossRef
Body mass index and waist-to-height ratio effect on mortality in non-alcoholic fatty liver: revisiting the obesity paradox
Hao Jiang, Mingkai Li, Hongsheng Yu, Yinan Huang, Bilan Yang, Bin Wu, Yidong Yang
Frontiers in Endocrinology.2024;[Epub]     CrossRef
Impact of Post-Thaw Enrichment of Primary Human Hepatocytes on Steatosis, Inflammation, and Fibrosis in the TruVivo® System
Justin J. Odanga, Sharon M. Anderson, Sharon C. Presnell, Edward L. LeCluyse, Jingsong Chen, Jessica R. Weaver
Pharmaceuticals.2024; 17(12): 1624.     CrossRef
Oral Pathogens’ Substantial Burden on Cancer, Cardiovascular Diseases, Alzheimer’s, Diabetes, and Other Systemic Diseases: A Public Health Crisis—A Comprehensive Review
Peter E. Murray, Jonathan A. Coffman, Franklin Garcia-Godoy
Pathogens.2024; 13(12): 1084.     CrossRef
A Survey Assessing Nonalcoholic Fatty Liver Disease Knowledge Among Hepatologists and Non‐Hepatologists in China
Laura Colombo
JGH Open.2024;[Epub]     CrossRef
Metabolomics at the cutting edge of risk prediction of MASLD
En Ying Tan, Mark D. Muthiah, Arun J. Sanyal
Cell Reports Medicine.2024; 5(12): 101853.     CrossRef
Differential Exercise Requirements for Nonalcoholic Fatty Liver Disease Resolution Across Age Groups: A Longitudinal Study of Korean Military Officers
Jaejun Lee, Dong Yeup Lee, Jae Hyeop Jung, Eunkyoung Bae, Jeong A. Yu, Hyun Yang
Journal of Physical Activity and Health.2024; : 1.     CrossRef
Editorial: Leveraging multi-omics approaches to understand and manage gastrointestinal and hepatic diseases
Isis Trujillo-Gonzalez, Paul G. Thomes, Isin Tuna Sakallioglu, Kusum K. Kharbanda
Frontiers in Pharmacology.2024;[Epub]     CrossRef
Non-alcoholic fatty liver disease among people living with HIV on long-term antiretroviral therapy in Indonesia: Prevalence and related factors
Hikmat Pramukti, Evy Yunihastuti, Rino A Gani, Ikhwan Rinaldi, Irsan Hasan, Suzy Maria
SAGE Open Medicine.2024;[Epub]     CrossRef
High-fat diet mouse model receiving L-glucose supplementations propagates liver injury
Johnny Amer, Athar Amleh, Ahmad Salhab, Yuval Kolodny, Shira Yochelis, Baker Saffouri, Yossi Paltiel, Rifaat Safadi
Frontiers in Nutrition.2024;[Epub]     CrossRef
Ablation of Hepatic Asah1 Gene Disrupts Hepatic Lipid Homeostasis and Promotes Fibrotic Non-Alcoholic Steatohepatitis in Mice
Rui Zuo, Mi Wang, Yun-Ting Wang, YangPing ShenTu, Alexandra K. Moura, Ying Zhou, Kiana Roudbari, Jenny Z. Hu, Pin-Lan Li, JiuKuan Hao, Xiang Li, Yang Zhang
The American Journal of Pathology.2024;[Epub]     CrossRef
Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Patients—The Relationship with Platelets Indicators
Danusia Onișor, Andrada Larisa Roiban, Simona Cernea
Medicina.2024; 60(12): 2091.     CrossRef
Assessment of Non-alcoholic Fatty Liver Disease and Level of Risk of Fibrosis in Diabetic and Non-diabetic Individuals
Miah Wahiduzzaman, Noor-E- Ferdous, K. M. Mozibul Haque, A. K. M. Shamsul Kabir, Md. Adib Siddiki, Md. Tanim Hossain , Qazi Ashrafur Rahman , Al Istiak Ur Rahman , A. H. M. Golam Kibria
Cureus.2024;[Epub]     CrossRef
A PRAGMATIC MANAGEMENT APPROACH FOR METABOLIC DYSFUNCTION ASSOCIATED STEATOSIS AND STEATOHEPATITIS
Neha Shah, Arun J. Sanyal
American Journal of Gastroenterology.2024;[Epub]     CrossRef
Endogenous n-3 PUFAs Improve Non-Alcoholic Fatty Liver Disease through FFAR4-Mediated Gut–Liver Crosstalk
Xuan Jiang, Qin Yang, Hongyan Qu, Yongquan Chen, Shenglong Zhu
Nutrients.2023; 15(3): 586.     CrossRef
Editorial: clinical outcomes in lean NAFLD—the devil is in the details
Eunice X. X. Tan, Mark Dhinesh Muthiah, Cheng Han Ng, Daniel Q. Huang
Alimentary Pharmacology & Therapeutics.2023; 57(9): 1040.     CrossRef
Noninvasive Assessment of Liver Fibrosis in NAFLD
Arun J. Sanyal, Laurent Castera, Vincent Wai-Sun Wong
Clinical Gastroenterology and Hepatology.2023; 21(8): 2026.     CrossRef
Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome
Hafeja Akhter Hima, Md Abdul Hannan Miah, Nipa Rani Ghosh, Sazia Sultana, Tanjina Akter, Fatema Tuz Zahura Aalpona, A. B. M. Kamrul-Hasan
Bangladesh Journal of Endocrinology and Metabolism.2023; 2(2): 80.     CrossRef
The Role of GLP1-RAs in Direct Modulation of Lipid Metabolism in Hepatic Tissue as Determined Using In Vitro Models of NAFLD
Ana Petrovic, Dunja Igrec, Karla Rozac, Kristina Bojanic, Lucija Kuna, Tea Omanovic Kolaric, Vjera Mihaljevic, Renata Sikora, Robert Smolic, Marija Glasnovic, George Y. Wu, Martina Smolic
Current Issues in Molecular Biology.2023; 45(6): 4544.     CrossRef
Close association of PFASs exposure with hepatic fibrosis than steatosis: evidences from NHANES 2017–2018
Wenli Cheng, Min Li, Luyun Zhang, Cheng Zhou, Xinyu Zhang, Chenyu Zhu, Luyi Tan, Hui Lin, Wenjuan Zhang, Wenji Zhang
Annals of Medicine.2023;[Epub]     CrossRef
Heterozygous midnolin knockout attenuates severity of nonalcoholic fatty liver disease in mice fed a Western-style diet high in fat, cholesterol, and fructose
Soo-Mi Kweon, Jose Irimia-Dominguez, Gayeoun Kim, Patrick T. Fueger, Kinji Asahina, Keith K. Lai, Daniela S. Allende, Quincy R. Lai, Chih-Hong Lou, Walter M. Tsark, Ju Dong Yang, Dominic S. Ng, Ju-Seog Lee, Patrick Tso, Wendong Huang, Keane K. Y. Lai
American Journal of Physiology-Gastrointestinal and Liver Physiology.2023; 325(2): G147.     CrossRef
Synergistic Preventive Effect of Aerobic and Resistance Exercises on Nonalcoholic Fatty Liver Disease
Ju-Yeon Cho, Won Sohn
Gut and Liver.2023; 17(4): 487.     CrossRef
Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments
Lucy Petagine, Mohammed Gulrez Zariwala, Vinood B Patel
World Journal of Gastroenterology.2023; 29(32): 4831.     CrossRef
Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic target
Yuan Yao, Yunfeng Shen
Open Life Sciences.2023;[Epub]     CrossRef
The silent burden of non‐alcoholic fatty liver disease in the elderly: A global burden of disease analysis
Pojsakorn Danpanichkul, Cheng Han Ng, Mark D. Muthiah, Kwanjit Duangsonk, Jie Ning Yong, Darren Jun Hao Tan, Wen Hui Lim, Zhen Yu Wong, Nicholas Syn, Tsubasa Tsusumi, Hirokazu Takahashi, Mohammad Shadab Siddiqui, Vincent Wai‐Sun Wong, Christos S. Mantzoro
Alimentary Pharmacology & Therapeutics.2023; 58(10): 1062.     CrossRef
Ameliorative Effects of Anthocyanin Metabolites on Western Diet-Induced NAFLD by Modulating Co-Occurrence Networks of Gut Microbiome
Hironobu Nakano, Kozue Sakao, Koji Wada, De-Xing Hou
Microorganisms.2023; 11(10): 2408.     CrossRef
Challenges and Solutions in the Management of Hepatocellular Carcinoma Associated with Non-Alcoholic Fatty Liver Disease
Ramona Cadar, Corina Lupascu Ursulescu, Alin Mihai Vasilescu, Ana Maria Trofin, Mihai Zabara, Delia Rusu-Andriesi, Bogdan Ciuntu, Cristina Muzica, Cristian Dumitru Lupascu
Life.2023; 13(10): 1987.     CrossRef
Uncovering the Cardiovascular Threat: A Comprehensive Examination of Liver Fibrosis and Subclinical Atherosclerosis in Non-alcoholic Fatty Liver Disease
Niketa Sharma, Swarupa Chakole, Bhushan Wandile
Cureus.2023;[Epub]     CrossRef
Unveiling the role of gut dysbiosis in non-alcoholic fatty liver disease
Pranali A. Jadhav, Asha B. Thomas, Rabindra K. Nanda, Sohan S. Chitlange
European Journal of Gastroenterology & Hepatology.2023; 35(12): 1324.     CrossRef
Decellularization Techniques for Tissue Engineering: Towards Replicating Native Extracellular Matrix Architecture in Liver Regeneration
Ishita Allu, Ajay Kumar Sahi, Meghana Koppadi, Shravanya Gundu, Alina Sionkowska
Journal of Functional Biomaterials.2023; 14(10): 518.     CrossRef
Recent insights into the pathogenesis and therapeutic targets of chronic liver diseases
Yankai Wen, Lichun Ma, Cynthia Ju
eGastroenterology.2023; 1(2): e100020.     CrossRef
Exploring the underlying mechanisms of Ashitaba in the management of non-alcoholic fatty liver disease by integrating the analysis of transcriptomics and metabolomics
Huan Yang, Yunshan Li, Weihong Xu, Wenjuan Liu, Ying Xie
Frontiers in Medicine.2023;[Epub]     CrossRef
The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
Teodora Biciusca, Sorina Ionelia Stan, Mara Amalia Balteanu, Ramona Cioboata, Alice Elena Ghenea, Suzana Danoiu, Ana-Maria Bumbea, Viorel Biciusca
Diagnostics.2023; 13(21): 3316.     CrossRef
Pegozafermin Is a Potential Master Therapeutic Regulator in Metabolic Disorders: A Review
Nadian N. Bailey, Stephen J. Peterson, Manish A. Parikh, Kaedrea A. Jackson, William H. Frishman
Cardiology in Review.2023;[Epub]     CrossRef
Pentadecanoic Acid (C15:0), an Essential Fatty Acid, Shares Clinically Relevant Cell-Based Activities with Leading Longevity-Enhancing Compounds
Stephanie Venn-Watson, Nicholas J. Schork
Nutrients.2023; 15(21): 4607.     CrossRef
Association or causation: still more questions than answers in early-onset gastrointestinal cancers
E. Fontana, I. Ben-Aharon
ESMO Gastrointestinal Oncology.2023; 1: 40.     CrossRef
The Role of Epigenetic Control of Mitochondrial (Dys)Function in MASLD Onset and Progression
Valerio Caputo, Giovanni Tarantino, Silvano Junior Santini, Giovanna Fracassi, Clara Balsano
Nutrients.2023; 15(22): 4757.     CrossRef
Unraveling the Connection between Fatty Liver Severity with Gender, Lifestyle, and Health Risks among Workers
Feng-Cheng Tang, Ren-Hau Li, Jui-Hua Huang
Nutrients.2023; 15(22): 4765.     CrossRef
Nonalcoholic Fatty Liver Disease as a Systemic Disease and the Need for Multidisciplinary Care
Masato Yoneda, Takashi Kobayashi, Michihiro Iwaki, Asako Nogami, Satoru Saito, Atsushi Nakajima
Gut and Liver.2023; 17(6): 843.     CrossRef
Editorial: Interactions between NAFLD and cardiac conduction, structure and function: recent advances and treatments
Christiano Argano
Frontiers in Endocrinology.2023;[Epub]     CrossRef
Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
Cheng-Wei Yu, Chia-Hung Chen, Yung-Chi Cheng, Wen-Che Hsieh, Tzu-Ju Hsu, Fuu-Jen Tsai, Chao-Yu Hsu
European Journal of Medical Research.2023;[Epub]     CrossRef
Trends of nonalcoholic fatty liver research in Southeast Asia from 2004 to 2022: A bibliometric analysis
Vivien Joyce D. Josol, Paul Benedic U. Salvador, Linnaeus Louisse A. Cruz, Eric David B. Ornos, Ourlad Alzeus G. Tantengco
Obesity Medicine.2023; : 100527.     CrossRef
Reduced Lipopolysaccharide-Binding Protein (LBP) Levels Are Associated with Non-Alcoholic Fatty Liver Disease (NAFLD) and Adipose Inflammation in Human Obesity
Ilaria Barchetta, Flavia Agata Cimini, Federica Sentinelli, Caterina Chiappetta, Claudio Di Cristofano, Gianfranco Silecchia, Frida Leonetti, Marco Giorgio Baroni, Maria Gisella Cavallo
International Journal of Molecular Sciences.2023; 24(24): 17174.     CrossRef
A Comprehensive Review on Non-Alcoholic Fatty Liver Disease
Prerna Sahu, Pratyaksh Chhabra, Ashok M Mehendale
Cureus.2023;[Epub]     CrossRef
Developmental Programming: Impact of Prenatal Exposure to Bisphenol A on Senescence and Circadian Mediators in the Liver of Sheep
Giuliana Motta, Soundara Viveka Thangaraj, Vasantha Padmanabhan
Toxics.2023; 12(1): 15.     CrossRef
Relationships between nonalcoholic fatty liver disease and polycystic ovary syndrome
E.H. Manzhalii, T.F. Tatarchuk, T.M. Tutchenko, N.V. Kosei, R.O. Mnevets
REPRODUCTIVE ENDOCRINOLOGY.2023; (70): 40.     CrossRef